{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:29:11Z","timestamp":1785230951089,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["No. 20-365"],"award-info":[{"award-number":["No. 20-365"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Jiao Tong University Integrated Innovation Fund","award":["No. 2020-01"],"award-info":[{"award-number":["No. 2020-01"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2300804"],"award-info":[{"award-number":["2021YFC2300804"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2301604"],"award-info":[{"award-number":["2021YFC2301604"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is a raising concern of a higher infectious Omicron BA.2 variant and the latest BA.4, BA.5 variant, made it more difficult in the mitigation process against COVID-19 pandemic. Our study aimed to find optimal control strategies by transmission of dynamic model from novel invasion theory.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Based on the public data sources from January 31 to May 31, 2022, in four cities (Nanjing, Shanghai, Shenzhen and Suzhou) of China. We segmented the theoretical curves into five phases based on the concept of biological invasion. Then, a spatial autocorrelation analysis was carried out by detecting the clustering of the studied areas. After that, we choose a mathematical model of COVID-19 based on system dynamics methodology to simulate numerous intervention measures scenarios. Finally, we have used publicly available migration data to calculate spillover risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Epidemics in Shanghai and Shenzhen has gone through the entire invasion phases, whereas Nanjing and Suzhou were all ended in the establishment phase. The results indicated that <jats:italic>Rt<\/jats:italic> value and public health and social measures (PHSM)-index of the epidemics were a negative correlation in all cities, except Shenzhen. The intervention has come into effect in different phases of invasion in all studied cities. Until the May 31, most of the spillover risk in Shanghai remained above the spillover risk threshold (18.81\u2013303.84) and the actual number of the spillovers (0.94\u201374.98) was also increasing along with the time. Shenzhen reported Omicron cases that was only above the spillover risk threshold (17.92) at the phase of outbreak, consistent with an actual partial spillover. In Nanjing and Suzhou, the actual number of reported cases did not exceed the spillover alert value.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Biological invasion is positioned to contribute substantively to understanding the drivers and mechanisms of the COVID-19 spread and outbreaks. After evaluating the spillover risk of cities at each invasion phase, we found the dynamic zero-COVID strategy implemented in four cities successfully curb the disease epidemic peak of the Omicron variant, which was highly correlated to the way to perform public health and social measures in the early phases right after the invasion of the virus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s40249-022-01039-y","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:18:52Z","timestamp":1669511932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimal control strategies of SARS-CoV-2 Omicron supported by invasive and dynamic models"],"prefix":"10.1186","volume":"11","author":[{"given":"Jia","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-8427","authenticated-orcid":false,"given":"Xiao-Nong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"1039_CR1","unstructured":"WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed 26 Nov 2021."},{"key":"1039_CR2","unstructured":"GISAID. Tracking of variants. 2022. https:\/\/www.gisaid.org\/hcov19-variants\/."},{"issue":"5","key":"1039_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.46234\/ccdcw2022.001","volume":"4","author":"Q Guo","year":"2022","unstructured":"Guo Q, Ruhan A, Liang L, Zhao X, Deng A, Hu Y, et al. An imported case of BA.2 lineage of Omicron variant COVID-19\u2014Guangdong Province, China, December 28, 2021. China CDC Wkly. 2022;4(5):98\u20139. https:\/\/doi.org\/10.46234\/ccdcw2022.001.","journal-title":"China CDC Wkly."},{"issue":"18","key":"1039_CR4","first-page":"377","volume":"4","author":"X Fan","year":"2022","unstructured":"Fan X, Lu S, Bai L, Liu H, Fu J, Jin X, et al. Preliminary study of the protectiveness of vaccination against the COVID-19 in the outbreak of VOC Omicron BA.2\u2014Jilin City, Jilin Province, China, March 3-April 12, 2022. China CDC Wkly. 2022;4(18):377\u201380.","journal-title":"China CDC Wkly."},{"key":"1039_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.11.22276273","author":"Z Chen","year":"2022","unstructured":"Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. medRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.06.11.22276273.","journal-title":"medRxiv."},{"key":"1039_CR6","doi-asserted-by":"crossref","unstructured":"Cheng SM, Mok CKP, Chan KC, Ng SS, Lam BH, Luk LL, et al. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022. Euro Surveill. 2022;27(18):2200178.","DOI":"10.2807\/1560-7917.ES.2022.27.18.2200178"},{"issue":"16","key":"1039_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532\u201346.","journal-title":"N Engl J Med."},{"issue":"5","key":"1039_CR8","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/jmv.27588","volume":"94","author":"Y Araf","year":"2022","unstructured":"Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, et al. Omicron variant of SARS-CoV-2: genomics, transmissibility, and responses to current COVID-19 vaccines. J Med Virol. 2022;94(5):1825\u201332.","journal-title":"J Med Virol"},{"issue":"7","key":"1039_CR9","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-022-01855-7","volume":"28","author":"J Cai","year":"2022","unstructured":"Cai J, Deng X, Yang J, Sun K, Liu H, Chen Z, et al. Modeling transmission of SARS-CoV-2 Omicron in China. Nat Med. 2022;28(7):1468\u201375.","journal-title":"Nat Med"},{"issue":"2","key":"1039_CR10","doi-asserted-by":"publisher","first-page":"E17-E","DOI":"10.1016\/S2213-2600(21)00559-2","volume":"10","author":"TK Burki","year":"2022","unstructured":"Burki TK. Omicron variant and booster COVID-19 vaccines. Lancet Resp Med. 2022;10(2):E17-E.","journal-title":"Lancet Resp Med."},{"issue":"10323","key":"1039_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(22)00056-3","volume":"399","author":"J Nealon","year":"2022","unstructured":"Nealon J, Cowling BJ. Omicron severity: milder but not mild. Lancet. 2022;399(10323):412\u20133.","journal-title":"Lancet"},{"key":"1039_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.07.22274792","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun K, Feng Z, Yi L, Wu Y, Liu H, et al. Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants. medRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.05.07.22274792.","journal-title":"medRxiv."},{"issue":"7916","key":"1039_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/d41586-022-01730-y","volume":"606","author":"E Callaway","year":"2022","unstructured":"Callaway E. What Omicron\u2019s BA.4 and BA.5 variants mean for the pandemic. Nature. 2022;606(7916):848\u20139.","journal-title":"Nature"},{"key":"1039_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106698","volume":"103","author":"RK Mohapatra","year":"2022","unstructured":"Mohapatra RK, Kandi V, Sarangi AK, Verma S, Tuli HS, Chakraborty S, et al. The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic\u2014correspondence. Int J Surg. 2022;103: 106698.","journal-title":"Int J Surg"},{"issue":"14","key":"1039_CR15","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","volume":"185","author":"A Tuekprakhon","year":"2022","unstructured":"Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185(14):2422-33.e13.","journal-title":"Cell"},{"key":"1039_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139565424","volume-title":"Invasion biology and ecological theory: contents","author":"H Prins","year":"2014","unstructured":"Prins H, Gordon IJ. Invasion biology and ecological theory: contents. Cambridge: Cambridge University Press; 2014."},{"issue":"6557","key":"1039_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.abj0113","volume":"373","author":"MUG Kraemer","year":"2021","unstructured":"Kraemer MUG, Hill V, Ruis C, Dellicour S, Bajaj S, McCrone JT, et al. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science. 2021;373(6557):889\u201395.","journal-title":"Science"},{"key":"1039_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3897\/neobiota.62.52463","volume":"62","author":"PE Hulme","year":"2020","unstructured":"Hulme PE, Baker R, Freckleton R, Hails RS, Hartley M, Harwood J, et al. The Epidemiological Framework for Biological Invasions (EFBI): an interdisciplinary foundation for the assessment of biosecurity threats. NeoBiota. 2020;62:161\u201392.","journal-title":"Neobiota"},{"issue":"3","key":"1039_CR19","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.181577","volume":"6","author":"NH Ogden","year":"2019","unstructured":"Ogden NH, Wilson JRU, Richardson DM, Hui C, Davies SJ, Kumschick S, et al. Emerging infectious diseases and biological invasions: a call for a One Health collaboration in science and management. R Soc Open Sci. 2019;6(3): 181577.","journal-title":"R Soc Open Sci"},{"issue":"6","key":"1039_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tree.2017.03.007","volume":"32","author":"A Ricciardi","year":"2017","unstructured":"Ricciardi A, Blackburn TM, Carlton JT, Dick JTA, Hulme PE, Iacarella JC, et al. Invasion science: a horizon scan of emerging challenges and opportunities. Trends Ecol Evol. 2017;32(6):464\u201374.","journal-title":"Trends Ecol Evol"},{"issue":"04","key":"1039_CR21","first-page":"239","volume":"102","author":"WN Liang","year":"2022","unstructured":"Liang WN, Liu M, Liu J, Wang YD, Wu J, Liu X. The dynamic COVID-zero strategy on prevention and control of COVID-19 in China. Zhonghua Yi Xue Za Zhi. 2022;102(04):239\u201342 (In Chinese).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"1039_CR22","unstructured":"Institute ME. The elimination strategy continues to protect people, economies and freedoms more effectively 2021. https:\/\/www.institutmolinari.org\/2021\/09\/21\/the-zero-covid-strategy-continues-to-protect-people-economies-and-freedoms-more-effectively\/."},{"key":"1039_CR23","unstructured":"World Health Organization. Public health criteria to adjust public health and social measures in the context of COVID-19: annex to considerations in adjusting public health and social measures in the context of COVID-19, 12 May 2020. World Health Organization, 2020."},{"key":"1039_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-34721-5","volume-title":"The ecology of invasions by animals and plants","author":"CS Elton","year":"2020","unstructured":"Elton CS. The ecology of invasions by animals and plants. Springer Nature: Springer; 2020."},{"issue":"34","key":"1039_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.46234\/ccdcw2020.181","volume":"2","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Yang M, Wang Y, Yao L, Chen T. Effectiveness of interventions to control transmission of reemergent cases of COVID-19\u2014Jilin Province, China, 2020. China CDC Wkly. 2020;2(34):651\u20134.","journal-title":"China CDC Wkly"},{"issue":"1","key":"1039_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40249-020-00640-3","volume":"9","author":"TM Chen","year":"2020","unstructured":"Chen TM, Rui J, Wang QP, Zhao ZY, Cui JA, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020;9(1):24.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"1039_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40249-020-00735-x","volume":"9","author":"ZY Zhao","year":"2020","unstructured":"Zhao ZY, Zhu YZ, Xu JW, Hu SX, Hu QQ, Lei Z, et al. A five-compartment model of age-specific transmissibility of SARS-CoV-2. Infect Dis Poverty. 2020;9(1):117.","journal-title":"Infect Dis Poverty."},{"issue":"1","key":"1039_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40249-021-00835-2","volume":"10","author":"SN Lin","year":"2021","unstructured":"Lin SN, Rui J, Chen QP, Zhao B, Yu SS, Li ZY, et al. Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study. Infect Dis Poverty. 2021;10(1):53.","journal-title":"Infect Dis Poverty"},{"key":"1039_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.701836","volume":"8","author":"Y Niu","year":"2021","unstructured":"Niu Y, Rui J, Wang Q, Zhang W, Chen Z, Xie F, et al. Containing the transmission of COVID-19: a modeling study in 160 countries. Front Med (Lausanne). 2021;8:701836.","journal-title":"Front Med (Lausanne)"},{"key":"1039_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-01544-w","author":"XN Zhou","year":"2020","unstructured":"Zhou XN. Science superpowers after COVID-19 lockdowns lift: a letter of hope from China to the United States. Nature. 2020. https:\/\/doi.org\/10.1038\/d41586-020-01544-w.","journal-title":"Nature"},{"issue":"4","key":"1039_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.46234\/ccdcw2022.015","volume":"4","author":"L Jue","year":"2022","unstructured":"Jue L, Min L, Wannian L. Perspectives: the dynamic COVID-Zero strategy in China. China CDC Weekly. 2022;4(4):74\u20135.","journal-title":"China CDC Weekly"},{"issue":"1","key":"1039_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40249-021-00880-x","volume":"10","author":"Y Ma","year":"2021","unstructured":"Ma Y, Mishra SR, Han XK, Zhu DS. The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments\u2019 Stringency Index from 148 countries. Infect Dis Poverty. 2021;10(1):96.","journal-title":"Infect Dis Poverty"},{"issue":"01","key":"1039_CR33","first-page":"1","volume":"20","author":"FH Wan","year":"2011","unstructured":"Wan FH, Yan Y, Wang R, Yang GQ. Invasion biology: development and perspective in China. J Biosafety. 2011;20(01):1\u201319 (In Chinese).","journal-title":"J Biosafety"},{"issue":"01","key":"1039_CR34","first-page":"1","volume":"19","author":"EX Gao","year":"2022","unstructured":"Gao EX. The balanced governance: how the TCE strategy succeed to prevent and control the COVID-19 A case study of a Chinese megacity. J Public Manag. 2022;19(01):1\u201312+164 (In Chinese).","journal-title":"J Public Manag."},{"key":"1039_CR35","unstructured":"WHO. Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities. 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-lab testing-20211-eng2021. Accessed 25 Jun 2021."},{"key":"1039_CR36","doi-asserted-by":"crossref","unstructured":"Han X, Li J, Chen Y, Li Y, Xu Y, Ying B, et al. SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment. Lancet. 2022:1690\u20131.","DOI":"10.1016\/S0140-6736(22)00577-3"},{"key":"1039_CR37","doi-asserted-by":"crossref","unstructured":"Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. 2022:eabn4947.","DOI":"10.1101\/2021.11.11.21266068"},{"key":"1039_CR38","doi-asserted-by":"crossref","unstructured":"Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9(2):E120-E9.","DOI":"10.1016\/S2214-109X(20)30452-6"},{"key":"1039_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.irfa.2021.102005","volume":"80","author":"A Samitas","year":"2022","unstructured":"Samitas A, Kampouris E, Polyzos S. COVID-19 pandemic and spillover effects in stock markets: a financial network approach. Int Rev Financ Anal. 2022;80: 102005.","journal-title":"Int Rev Financ Anal"},{"key":"1039_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.eneco.2021.105498","volume":"102","author":"DK Si","year":"2021","unstructured":"Si DK, Li XL, Xu X, Fang Y. The risk spillover effect of the COVID-19 pandemic on energy sector: evidence from China. Energ Econ. 2021;102: 105498.","journal-title":"Energ Econ"},{"key":"1039_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/13548166211053670","author":"O Abdelsalam","year":"2021","unstructured":"Abdelsalam O, Aysan AF, Cepni O, Disli M. The spillover effects of the COVID-19 pandemic: which subsectors of tourism have been affected more? Tourism Econ. 2021. https:\/\/doi.org\/10.1177\/13548166211053670.","journal-title":"Tourism Econ"},{"key":"1039_CR42","unstructured":"Bouchnita A, Fox SJ, Lachmann JLH-DM, Herrera-Diestra GG, Meyers LA. COVID-19 scenario projections: The emergence of Omicron in the US-January 2022. The University of Texas COVID-19 Modeling Consortium. 2022."},{"key":"1039_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.20.21268130","author":"N Garret","year":"2021","unstructured":"Garret N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, et al. High rate of asymptomatic carriage associated with variant strain Omicron. MedRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.12.20.21268130.","journal-title":"MedRxiv"},{"issue":"1","key":"1039_CR44","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1093\/cid\/ciac237","volume":"75","author":"N Garrett","year":"2022","unstructured":"Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, et al. High asymptomatic carriage with the Omicron variant in South Africa. Clin Infect Dis. 2022;75(1):e289\u201392.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1039_CR45","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/ije\/dyx039","volume":"46","author":"J Benjamin-Chung","year":"2017","unstructured":"Benjamin-Chung J, Abedin J, Berger D, Clark A, Jimenez V, Konagaya E, et al. Spillover effects on health outcomes in low-and middle-income countries: a systematic review. Int J Epidemiol. 2017;46(4):1251\u201376.","journal-title":"Int J Epidemiol"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-022-01039-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01039-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:28:53Z","timestamp":1669512533000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-022-01039-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1186\/s40249-022-01039-y","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Xiao-Nong Zhou is an Editor-in-Chief of\u00a0the journal <i>Infectious<\/i><i>Diseases<\/i><i>of<\/i><i>Poverty<\/i>. Shang Xia is a member of Editorial Board of the journal. Jin Chen is an editor of the journal. They were not involved in the peer-review or handling of the manuscript. The authors have no other competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}